Global ambulatory care services market is expected to witness a great profit in the coming years because of increasing demand for home healthcare service by patients as it is more convenient and less stressful. The Outpatient care is being provided efficiently and economically. The ambulatory care includes diagnosis, observation, consultation, treatment, intervention, and rehabilitation services with advanced medical technologies due to which the need for in-patient care is reduced. Ambulatory care services is one of the major contributors to the hospital revenue and to the performance of the health care system. In addition, telephone consultations, rehabilitation visits, and emergency visits to the patients along with the normal visits, expected to attract more patients towards these services which offers a great contribution to financial outcome.
Rising Geriatric Population
The key factors that drive the market are growing incidences of various chronic diseases, According to WHO chronic diseases were responsible for 38 million (68%) of the world’s 56 million deaths in 2012. and the advances in technology and rising geriatric population is rising the market as per the data from World Population Prospects, between 2015 and 2030, the number of people with age 60 years and over is estimated to grow by 56%, from 901 million to 1.4 billion globally. The high demand for minimally invasive surgeries also contributes to the growth of ambulatory service market as patients recover faster in shorter duration of time with less charges in comparison to in-patient centers. Thereby, the cost-efficiency of the well-equipped ambulatory service centers is a key driver for its market growth. and others factors such as new reimbursement rules set by the government, rising chronic diseases and technology advancements are also driving the market.
Frequent Missed/Delayed Diagnosis
The constraints for this service include missed/delayed diagnosis and the incidence of adverse drug events (ADE), the adverse drug events are increasing every year, according to the United States department of health and human services these ADEs result in more than 770,000 injuries and deaths each year and may cost up to USD 5.6 million per hospital. Along with the others factors such as adverse drug events and ineffective communication are the major restraints for the growth of the market.
North America to dominate the Market
North America was the largest regional market with revenue share estimated at over 40% owing to increasing population with chronic diseases and favorable reimbursement for ambulatory services in the United States. While Asia-Pacific was estimated to register the fastest CAGR through the forecast period, 2018-2023.
Key Developments in the Market
- December 2017: Surgery Center of Long Beach (SCLB) is First in the Nation to Receive AAAHC’s New Orthopaedic Certification.
- December 2017: UnitedHealth Group's Optum announced Wednesday that it is buying DaVita Medical Group.
Reasons to Purchase this Report
- Current and future Ambulatory health care service market outlook in the developed and emerging markets
- Analyzing various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares and strategies employed by the major market players.
- 3 months analyst support along with the Market Estimate sheet in excel.
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCIDENCE OF CHRONIC DISEASES
6.1.2 ADVANCES IN TECHNOLOGY
6.1.3 DEMAND FOR MINIMALLY INVASIVE SURGERIES
6.1.4 RISING GERIATRIC POPULATION
6.1.5 REIMBURSEMENT RULES
6.2 MARKET RESTRAINTS
6.2.1 MISSED/DELAYED DIAGNOSIS
6.2.2 INCIDENCE OF ADVERSE DRUG EVENTS
6.2.3 INEFFECTIVE COMMUNICATION
6.4 KEY CHALLENGES
7. Market Segmentation
7.1 BY SURGERY TYPE
7.1.4 PAIN MANAGEMENT
7.1.5 OTHER END USE SECTORS
7.2 BY APPLICATION
7.2.1 LACERATION TREATMENT
7.2.2 BONE FRACTURE TREATMENT
7.2.3 EMERGENCY CARE SERVICE
7.2.4 TRAUMA OR ACCIDENT TREATMENT
7.3 BY PRODUCT TYPE
7.3.1 OUTPATIENT DEPARTMENTS
7.3.2 PRIMARY CARE OFFICES
7.3.3 SURGICAL SPECIALTY OFFICES
7.3.4 EMERGENCY DEPARTMENTS
7.3.5 MEDICAL SPECIALTY OFFICES
7.4 BY GEOGRAPHY
7.4.1 NORTH AMERICA
188.8.131.52 REST OF EUROPE
184.108.40.206 SOUTH KOREA
220.127.116.11 REST OF APAC
7.4.4 MIDDLE EAST AND AFRICA
18.104.22.168 SOUTH AFRICA
22.214.171.124 REST OF MIDDLE EAST AND AFRICA
7.4.5 SOUTH AMERICA
126.96.36.199 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.2 APRIA HEALTHCARE
9.3 DAVITA HEALTHCARE
9.4 LVL MEDICAL GROUP
9.5 FRESENIUS KABI
9.6 SONIC HEALTHCARE
9.7 HOSPITAL CORPORATION OF AMERICA (HCA) HOLDING
9.8 INTERGRAMED AMERICA INC.
9.9 SYMBION INC.
10. FUTURE OUTLOOK OF THE MARKET